title: The character of gene expression of human periosteum used to form new tissue in allograft bone.
abstract: Of more than 2 million segmental bone defects repaired annually with bone autografts and allografts, 15-40% fail. Improving healing rates may be approached with tissue engineering and use of periosteum overlying an allograft. The present study documents gene expression in human periosteum-allograft constructs compared to allografts alone. Strips of human cadaveric periosteum (26 years, f, distal femur) were sutured about sterilized human femoral cortical strut bone allograft (54 years, m) segments. After construct incubation (M199 supplemented medium) for 8 d, constructs and allografts alone were implanted in nude mice. At 10 and 20 weeks, constructs (N = 4, each group) and allografts (N = 2, each group) were retrieved and placed in RNAlater for quantitative PCR to determine expression of human- and murine-specific genes relevant to remodeling. Specimens were frozen-ground to powders and RNA was extracted, purified, reverse-transcribed, and amplified. Ribosomal protein (P0) was used to normalize sample quantities. Fold change plots were generated following statistical analyses comparing 20- to 10-week gene expression data. Allografts alone yielded no human-specific gene expression. Notable fold changes of human-specific alkaline phosphatase, bone sialoprotein, type I collagen, decorin, RANKL, RANK, cathepsin K, and osteocalcin in 20-week compared to 10-week specimens were found. Murine-specific expression of genes indicative of host mouse vascularization (RANK, type I collagen) was detected in both allograft alone and periosteum-allograft samples. Gene data confirm viable periosteum in constructs after 20 weeks. Relatively higher fold-change values of RANK, RANKL and cathepsin K indicate activities of osteoclast precursors, osteoclasts and osteoblasts involved in allograft remodeling during implantation. All additional genes of interest indicate osteoblast activity in new bone matrix formation. Gene data are directly correlated with previous and present histology work. The results of this study suggest that further investigations could help to establish whether autologous periosteum-allograft constructs could be used for the repair of bone defects.
authors.affiliation: Department of Polymer Science, Goodyear Polymer Center, University of Akron , Akron, OH , USA .
authors.forename: Jessica
authors.initials: J
authors.lastname: Kemppainen
authors.forename: Qing
authors.initials: Q
authors.lastname: Yu
authors.forename: John
authors.initials: J
authors.lastname: Alexander
authors.forename: Robin
authors.initials: R
authors.lastname: Jacquet
authors.forename: Thomas
authors.initials: T
authors.lastname: Scharschmidt
authors.forename: William
authors.initials: W
authors.lastname: Landis
mesh_terms: D064591:Allografts / Q000378:metabolism*; D000818:Animals; D016025:Bone Transplantation / Q000379:methods; D001842:Bone and Bones / Q000378:metabolism*; D015870:Gene Expression / Q000502:physiology*; D006801:Humans; D051379:Mice; D010521:Periosteum / Q000378:metabolism*; D023822:Tissue Engineering
keywords: Allograft bone; fracture healing; gene expression; periosteum; tissue engineering